Mitral valve
The one-way door between the left atrium and the left ventricle: it opens wide in diastole to let the ventricle fill, and seals shut in systole so that the whole stroke volume goes forward to the aorta.
What it normally does
Two leaflets — a tall anterior leaflet and a broader, scalloped posterior one — coapt to seal the atrioventricular opening throughout systole. The left ventricle generates around 120 mmHg while the left atrium stays near 10 mmHg, so any gap in that seal drives blood backwards down a gradient of roughly 100 mmHg. That gradient exists from the first moment of ventricular contraction to the last, which is why a leaking mitral valve gives a murmur that occupies the whole of systole.
mitral regurgitation is pansystolic and starts with (and can bury) the first heart sound — and because loudness tracks turbulence rather than regurgitant volume, a quiet murmur does not mean a small leak.
In diastole the orifice opens to roughly 4–6 cm² in an adult, and the ventricle fills largely passively at a mean left atrial pressure of only about 8–12 mmHg, with atrial contraction adding the last fifth or so of filling volume. Forward flow across the valve happens only in diastole — systole is spent with the valve shut.
anything that narrows the orifice, or shortens diastole (tachycardia), or removes the atrial kick (atrial fibrillation) forces left atrial pressure up, and that pressure passes straight back into the pulmonary veins and capillaries.
The leaflets are tethered by chordae tendineae to two papillary muscles that contract with the ventricle and stop the leaflets everting into the atrium. The posteromedial papillary muscle is usually supplied by a single artery (the posterior descending, most often from the right coronary); the anterolateral muscle has a dual supply.
rupture a chorda or infarct the posteromedial papillary muscle and the seal fails instantly, while chronic elongation of chordae lets the leaflet balloon backwards (prolapse) — the tethering apparatus, not the leaflet alone, is what fails.
The left atrium is a thin-walled, low-pressure, compliant chamber. Loaded slowly it stretches and accommodates large volumes for years at modest pressure; loaded suddenly, before it has remodelled, it sits on the steep part of its pressure–volume curve. A chronically stretched, fibrosed atrium also fibrillates and forms thrombus, classically in the appendage.
the same regurgitant volume gives years of compensated breathlessness when it arrives gradually and flash pulmonary oedema when it arrives in one beat — and it explains why atrial fibrillation and systemic embolism are the shared complications of both mitral stenosis and chronic mitral regurgitation.
The leaflets are thin, largely avascular folds of endocardium over a collagen core, kept competent by intact commissures, pliable leaflet tissue and chordae of the right length. This tissue heals by fibrosis and calcification, not by regeneration.
immune-mediated valvulitis, myxomatous degeneration and infective destruction all end in fixed scarring — so no drug restores a mitral valve, and definitive treatment is mechanical (balloon commissurotomy, surgical repair or replacement).
What goes wrong
- Acute rheumatic fever and rheumatic heart disease← from “The leaflets are thin, largely avascular folds…”
The immune response to a group A streptococcal infection — classically pharyngitis, with skin infection also implicated in high-burden Australian settings — cross-reacts with valve tissue by molecular mimicry, both antibody and T-cell mediated, typically a couple of weeks after the infection. Acute valvulitis makes the leaflets swell and coapt poorly, so the first attack causes regurgitation, not stenosis. Each episode heals by fibrosis, and recurrent episodes add more, until the thin pliable leaflets and free commissures of the normal valve become thickened, fused and immobile — which is where stenosis comes from, years later.
First attack leaks, repeat attacks scar and fuse: acute rheumatic carditis gives mitral regurgitation, chronic rheumatic disease gives mitral stenosis. Diagnosis is clinical criteria plus echo plus streptococcal serology, with a lower threshold in high-risk populations. Acute rheumatic fever and rheumatic heart disease are notifiable in the Australian jurisdictions running register-based control programs, and the register is what delivers secondary prophylaxis — which is the only intervention that changes the valve's trajectory.
You would find: A child or young adult with fever, migratory large-joint arthritis and a new murmur. Under the Australian (high-risk population) modification of the Jones criteria, monoarthritis and polyarthralgia also count, because the classic migratory picture is often blunted by early analgesia. In Australia this burden sits overwhelmingly with Aboriginal and Torres Strait Islander peoples, especially in remote parts of the NT, WA, Qld and SA, where rates are among the highest recorded anywhere; Māori and Pacific Islander peoples living in Australia are also at increased risk. Acute rheumatic fever remains a clinical diagnosis backed by evidence of preceding streptococcal infection, usually serological (ASOT, anti-DNase B), because the throat swab is often negative by the time symptoms appear. RHDAustralia guidance is that every suspected case gets an echocardiogram, since carditis is frequently subclinical — and echocardiography is also what diagnoses established rheumatic heart disease. Sore throats and skin sores in these communities are treated, not watched.
- Mitral stenosis← from “In diastole the orifice opens to roughly 4–6 c…”
Rheumatic scarring fuses the commissures and thickens and retracts the leaflets and chordae, so the 4–6 cm² diastolic opening narrows towards 1 cm². The atrium can now only push blood through by generating a pressure gradient across the valve, so left atrial pressure rises and is transmitted back into the pulmonary veins and capillaries; sustained elevation produces pulmonary hypertension and eventually right heart failure. The dilated atrium fibrillates, blood stagnates in the appendage, and thrombus forms.
Severity is echocardiographic, not auscultatory: a valve area of about 1.5 cm² or less is severe, and the mean gradient is rate-dependent so a low gradient in a bradycardic patient does not exclude severe disease. A shorter interval between the second sound and the opening snap means higher left atrial pressure and tighter stenosis, and both the loud S1 and the snap disappear once the valve is rigidly calcified. Drugs buy diastole and dry the lungs; the valve is fixed by percutaneous balloon mitral commissurotomy in suitable pliable non-calcified valves without significant regurgitation or left atrial thrombus, otherwise by surgery.
You would find: Exertional breathlessness progressing to breathlessness at rest, sometimes haemoptysis. A loud first heart sound, an opening snap after the second sound, and a low-pitched rumbling mid-diastolic murmur at the apex, heard with the bell, patient rolled into the left lateral position; a tapping apex, and with pulmonary hypertension a right ventricular heave and loud P2. An irregularly irregular pulse means atrial fibrillation — and the patient often decompensates on the day it starts, because the fast rate steals the diastole they depend on and they lose the atrial contraction that was supplying the last fifth of filling.
- Chronic mitral regurgitation← from “Two leaflets — a tall anterior leaflet and a b…”
The systolic seal fails — prolapsing myxomatous leaflets or ruptured chordae (primary, degenerative disease), rheumatic scarring, or an annulus stretched and papillary muscles displaced by a dilated or ischaemic ventricle (secondary, functional disease). Every systole part of the stroke volume goes backwards into the atrium instead of the aorta. The atrium dilates, remodels and fibrillates; the ventricle volume-overloads and dilates eccentrically, and because it is ejecting partly into a low-pressure chamber it looks deceptively well for years before contractile function and forward output fall.
In asymptomatic severe primary mitral regurgitation, surgery is indicated once the ejection fraction falls to 60% or below, or the left ventricular end-systolic diameter reaches about 40 mm — a 'normal-looking' 60% here is already a failing ventricle. Echocardiographic severity uses regurgitant volume, regurgitant fraction and effective regurgitant orifice area rather than murmur loudness. Repair beats replacement for degenerative disease; transcatheter edge-to-edge repair is an option for selected patients unfit for surgery. Distinguish primary (valve is the problem — fix the valve) from secondary (ventricle is the problem — treat heart failure first).
You would find: A blowing pansystolic murmur at the apex radiating to the axilla, a soft first heart sound, a displaced hyperdynamic apex beat and often a third heart sound, with exertional fatigue and breathlessness. Beware the ejection fraction: part of each beat empties into a low-pressure atrium, so the ventricle can look like a good pump when it is not, and the thresholds that trigger action are set higher than in other diseases.
- Acute mitral regurgitation← from “The left atrium is a thin-walled, low-pressure…”
A chorda ruptures, or a papillary muscle infarcts and ruptures — classically the posteromedial muscle after an inferior myocardial infarction, because its single blood supply gives it no collateral protection. The tether that held the leaflet shut is gone, and a normal-sized, unremodelled left atrium receives a large regurgitant volume while sitting on the steep part of its pressure–volume curve, so left atrial pressure climbs abruptly and is transmitted directly to the pulmonary capillaries. Forward stroke volume collapses at the same time. Other causes: infective endocarditis destroying a leaflet, and chordal rupture in myxomatous disease.
Flash pulmonary oedema plus shock plus an unimpressive murmur, days after an inferior infarct: think papillary muscle rupture. The atrium's lack of time to remodel — not the size of the leak — is what makes it lethal. It is a surgical emergency; vasodilators, an intra-aortic balloon pump and ventilatory support are a bridge to theatre, not a treatment.
You would find: Sudden severe breathlessness, pink frothy sputum and hypotension, typically a few days after a myocardial infarction. The murmur may be short, early-systolic or inaudible because atrial and ventricular pressures equalise so quickly — a quiet chest in a crashing patient does not exclude it. Urgent echocardiography (transoesophageal if the transthoracic study is inconclusive) and immediate cardiothoracic surgical referral.
- Mitral valve prolapse← from “The leaflets are tethered by chordae tendineae…”
Myxomatous change makes the leaflets redundant and floppy and elongates the chordae, so as the ventricle empties in mid-systole a leaflet balloons back past the annular plane into the atrium. The chordae snap taut as it does — the click — and the seal breaks late in systole, giving a late systolic murmur.
Click then late systolic murmur, moving earlier and longer on standing or Valsalva — the one murmur that gets louder and longer when the ventricle gets smaller. Mostly benign and followed by echocardiography; the concerns are progression to severe regurgitation, chordal rupture and, in a minority with bileaflet prolapse and inferolateral T-wave changes or ventricular ectopy, arrhythmia.
You would find: A mid-systolic click followed by a late systolic murmur at the apex. Manoeuvres that reduce ventricular volume — standing from squatting, or the strain phase of Valsalva — let the leaflet prolapse earlier, so the click moves earlier and the murmur lengthens; squatting and handgrip do the opposite. It affects a few per cent of the population and is usually benign, but degenerative myxomatous disease is the commonest cause of primary mitral regurgitation in Australia, and some progress to severe regurgitation or chordal rupture.
What we give, and how it works
Open a drug to see what it binds, what that does to the cell, and what you then see in the patient.
- Binds
- Bacterial penicillin-binding proteins (transpeptidases) in the group A streptococcal cell wall — there is no human target.
- Which does
- Peptidoglycan cross-linking is blocked and autolysins are left unopposed, so dividing organisms lyse; group A streptococcus has remained uniformly penicillin-susceptible.
- So you see
- Streptococcal pharyngitis and pyoderma are treated or prevented, so the antigenic trigger for the cross-reactive valvulitis does not recur and further scarring of the mitral valve is prevented.
- And the same mechanism causes
- Because the target is bacterial, systemic toxicity is minimal; the mechanism-linked problems are the depot itself — a genuinely painful injection site, the single biggest driver of missed doses — and immune recognition of the beta-lactam, giving rash through to anaphylaxis, which is why a reported penicillin allergy is properly evaluated rather than assumed before switching to an alternative.
- Handling
- The benzathine salt is a depot: it dissolves slowly from the injection site to hold a low sustained penicillin concentration, which is what allows dosing measured in weeks. It must be given deep intramuscularly and never intravenously.
Catches people out: This is the drug on the page that actually preserves valve tissue, and it fails for social and logistic reasons rather than pharmacological ones. Australian practice (RHDAustralia and Therapeutic Guidelines) gives secondary prophylaxis 4-weekly, with 21-day dosing considered for breakthrough disease, and for longer than the older overseas figures: after acute rheumatic fever with no resulting rheumatic heart disease, a minimum of 10 years after the most recent episode or until age 21, whichever is longer, extending commonly to about age 35 with mild disease and age 40 with moderate disease, and continuing indefinitely with severe disease. Injection pain is a major reason doses are missed, so recall systems, register-based follow-up and pain reduction (lidocaine, still widely called lignocaine, may be added to the ready-filled syringe as the Australian guideline describes) are part of the plan. The category, dose and end date come from the current guideline for the individual patient, not from this page.
- Binds
- β1 adrenoceptors on nodal and myocardial cells (metoprolol, bisoprolol, atenolol); L-type calcium channels in sinoatrial and AV nodal tissue (verapamil, diltiazem); the myocyte Na+/K+-ATPase plus a vagally mediated action on the AV node (digoxin).
- Which does
- Beta blockade lowers cyclic AMP and protein kinase A activity, so the pacemaker current and L-type calcium entry are less phosphorylated and nodal cells depolarise and conduct more slowly. The calcium channel blockers remove the calcium current that carries the nodal action potential directly. Digoxin raises vagal outflow, increasing AV nodal refractoriness, while Na+/K+-ATPase inhibition raises intracellular calcium and gives mild inotropy.
- So you see
- A slower ventricular rate lengthens diastole, giving more time for blood to cross the narrowed orifice, so left atrial and pulmonary venous pressure fall and the patient becomes less breathless on exertion.
- And the same mechanism causes
- The intended nodal slowing taken too far: bradycardia, AV block, fatigue and blunted exercise heart rate. Verapamil and diltiazem carry the negative inotropy of the same calcium blockade, so they can precipitate decompensation in a failing ventricle; beta blockade spilling onto β2 receptors can provoke bronchospasm and mask adrenergic warning signs of hypoglycaemia; digoxin toxicity (nausea, visual disturbance, and arrhythmias from calcium overload) follows directly from pump inhibition.
- Handling
- Digoxin is renally cleared with a narrow therapeutic index, and hypokalaemia — readily produced by the loop diuretic these patients are usually also taking — increases its binding to Na+/K+-ATPase and its toxicity.
Catches people out: In mitral stenosis it is the heart rate, not the valve area alone, that decompensates the patient: fever, pregnancy, exercise, anaemia or new atrial fibrillation shorten diastole and can tip a previously stable patient into pulmonary oedema. Digoxin controls the resting rate but not the exertional rate, so it is a poor sole agent in an active patient. Verapamil and diltiazem depress contractility and are avoided when the left ventricle is already failing, and neither they nor digoxin are appropriate where pre-excited atrial fibrillation is a possibility.
- Binds
- NKCC2 in the thick ascending limb, binding at the chloride site of the cotransporter.
- Which does
- Sodium, potassium and chloride reabsorption in that segment is abolished, and with it the medullary concentrating gradient, so a large fraction of the filtered sodium load is delivered distally and lost.
- So you see
- Brisk natriuresis and diuresis, falling pulmonary capillary wedge pressure, and relief of orthopnoea, crackles and peripheral oedema; an early venodilator effect gives some symptomatic benefit before the urine appears.
- And the same mechanism causes
- Increased distal sodium delivery drives potassium and hydrogen ion loss, giving hypokalaemia and metabolic alkalosis — and hypokalaemia is exactly what precipitates digoxin toxicity in the same patient. Magnesium and calcium reabsorption in that segment is lost too (hypomagnesaemia, hypocalcaemia), excessive volume loss causes hypotension and prerenal impairment, and NKCC1 in the inner ear accounts for dose-related ototoxicity.
- Handling
- Oral bioavailability is variable and gut wall oedema in decompensated failure reduces absorption, which is why the intravenous route is used in acute pulmonary oedema.
Catches people out: It treats the pressure behind the valve, never the valve itself. Over-diurese someone with tight mitral stenosis and you remove the very filling pressure needed to drive blood through a narrow orifice: the lungs clear and the cardiac output falls. The aim is to relieve congestion, not to render the patient volume-depleted.
- Binds
- Vitamin K epoxide reductase complex subunit 1 (VKORC1) in hepatocytes.
- Which does
- Reduced vitamin K cannot be regenerated, so gamma-carboxylation of factors II, VII, IX and X — and of the natural anticoagulants protein C and protein S — fails, and the factors are released in a functionally inactive form.
- So you see
- Progressive anticoagulation measured by the INR, and a large reduction in stroke and systemic embolism from left atrial or prosthetic valve thrombus. Because existing carboxylated factors must first be cleared, full effect takes several days rather than hours.
- And the same mechanism causes
- Bleeding is the mechanism itself carried too far, and is reversed with vitamin K plus factor replacement rather than by simply stopping the drug. The short half-life of protein C relative to prothrombin means the first day or two can be net procoagulant, which is the basis of warfarin-induced skin necrosis and of heparin overlap when starting for acute thrombosis.
- Handling
- Effect varies with dietary vitamin K intake and with drugs affecting CYP2C9 and the gut flora, so it demands regular INR monitoring. It crosses the placenta and is teratogenic, which makes pregnancy in a young woman with rheumatic valve disease or a mechanical valve a specialist decision, not a routine one.
Catches people out: This is the exception exams love. Rheumatic mitral stenosis with atrial fibrillation, and mechanical valves, need warfarin with INR monitoring; the direct oral anticoagulants (apixaban, rivaroxaban, dabigatran) are not used for either — the INVICTUS trial found higher mortality with rivaroxaban than with a vitamin K antagonist in rheumatic heart disease with atrial fibrillation, and RE-ALIGN was stopped for more thromboembolism and more bleeding with dabigatran in mechanical valves. These are the two lesions that still count as 'valvular' atrial fibrillation, and here the valve lesion is itself the reason to anticoagulate, so the CHA2DS2-VASc score (validated in non-valvular atrial fibrillation, weighting heart failure, hypertension, age, diabetes, prior stroke or TIA, vascular disease and sex) does not decide it. The INR target depends on the indication and the prosthesis and is a prescribing decision, not a number to carry away from this page.
- Binds
- Soluble guanylate cyclase in vascular smooth muscle, via nitric oxide released from nitroprusside spontaneously and from glyceryl trinitrate after bioactivation (largely by mitochondrial aldehyde dehydrogenase); angiotensin-converting enzyme (kininase II) on endothelium for the ACE inhibitors.
- Which does
- Raised cyclic GMP activates protein kinase G, lowering intracellular calcium and relaxing the smooth muscle cell — nitroprusside acting on arteries and veins roughly equally, glyceryl trinitrate on veins at usual doses. ACE inhibition reduces angiotensin II generation, so AT1-mediated Gq signalling and aldosterone release fall, while bradykinin accumulates.
- So you see
- Systemic vascular resistance falls, so more of each stroke volume goes forward to the aorta and less back into the atrium: forward output rises, the regurgitant volume and left atrial v wave fall, and the pulmonary oedema clears.
- And the same mechanism causes
- The same vasodilatation where it is not wanted: hypotension with reflex tachycardia, which is dangerous precisely where output is preload-dependent or the outflow is fixed, and throbbing headache and flushing with the nitrates. For ACE inhibitors, loss of efferent glomerular arteriolar tone lowers GFR and loss of aldosterone drive causes hyperkalaemia, while accumulated bradykinin explains the dry cough and angio-oedema; they are contraindicated in pregnancy.
- Handling
- Nitroprusside is metabolised to cyanide and thiocyanate, which accumulate with prolonged high-dose infusion and in renal impairment, so it belongs in a monitored setting; where it is not readily available, a titrated glyceryl trinitrate infusion is the practical substitute. Continuous nitrate exposure produces tolerance within about a day.
Catches people out: No drug repairs a leaking valve — repair or replacement is the treatment, and its timing hinges on symptoms and on ventricular size and function on echocardiography, not on how loud the murmur is. Vasodilators are generally avoided in mitral stenosis: the obstruction is fixed, so forward output cannot rise to fill a dilated circulation, and the reflex tachycardia shortens the diastole the patient depends on.
A rumbling mid-diastolic murmur at the apex with an opening snap is stenosis; a pansystolic murmur radiating to the axilla is regurgitation; a mid-systolic click with a late systolic murmur is prolapse. Then ask why the stenotic patient decompensated today — fever, pregnancy, exercise, anaemia or new atrial fibrillation all shorten diastole, and diastole is the only time blood crosses that valve forwards, so the question is what stole the diastole, not just how much fluid to shift. In regurgitation, distrust a normal-looking ejection fraction: 60% is already the threshold for intervening in asymptomatic severe primary disease. And in an Aboriginal or Torres Strait Islander patient under 40 with a new mitral murmur, rheumatic heart disease sits at the top of the list until echocardiography says otherwise.
Now test whether it stuck
Reading this through is not the same as being able to reconstruct it. Every question in the bank is free, with a full debrief on each option.